Gossypol Interferes with Both Type I and Type II Topoisomerase Activities Without Generating Strand Breaks

被引:12
作者
Senarisoy, Muge [1 ]
Canturk, Pakize [1 ]
Zencir, Sevil [2 ]
Baran, Yusuf [3 ]
Topcu, Zeki [4 ]
机构
[1] Ege Univ, Grad Sch Nat & Appl Sci, Dept Biotechnol, TR-35100 Izmir, Turkey
[2] Pamukkale Univ, Fac Med, Dept Med Biol, Denizli, Turkey
[3] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey
[4] Ege Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-35100 Izmir, Turkey
关键词
DNA topoisomerases; Gossypol; Anticancer drug research; DNA strand breaks; BIOLOGICAL-ACTIVITY; DNA TOPOISOMERASES; CELLS; INHIBITION;
D O I
10.1007/s12013-012-9468-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A considerable number of agents with chemotherapeutic potentials reported over the past years were shown to interfere with the reactions of DNA topoisomerases, the essential enzymes that regulate conformational changes in DNA topology. Gossypol, a naturally occurring bioactive phytochemical is a chemopreventive agent against various types of cancer cell growth with a reported activity on mammalian topoisomerase II. The compounds targeting topoisomerases vary in their mode of action; class I compounds act by stabilizing covalent topoisomerase-DNA complexes resulting in DNA strand breaks while class II compounds interfere with the catalytic function of topoisomerases without generating strand breaks. In this study, we report Gossypol as the interfering agent with type I topoisomerases as well. We also carried out an extensive set of assays to analyze the type of interference manifested by Gossypol on DNA topoisomerases. Our results strongly suggest that Gossypol is a potential class II inhibitor as it blocked DNA topoisomerase reactions with no consequently formed strand breaks.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 23 条
[1]  
ADLAKHA RC, 1989, CANCER RES, V49, P2052
[2]   1H-benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors [J].
Alpan, A. Selcen ;
Gunesi, H. Sernih ;
Topcu, Zeki .
ACTA BIOCHIMICA POLONICA, 2007, 54 (03) :561-565
[3]   Reversible inhibition of calcineurin by the polyphenolic aldehyde gossypol [J].
Baumgrass, R ;
Weiwad, M ;
Erdmann, F ;
Liu, JO ;
Wunderlich, D ;
Grabley, S ;
Fischer, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :47914-47921
[4]  
Canturk P, 2008, ARZNEIMITTELFORSCH, V58, P686
[5]   Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays [J].
Coban, Gunes ;
Zencir, Sevil ;
Zupko, Istvan ;
Rethy, Borbala ;
Gunes, H. Semih ;
Topcu, Zeki .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (05) :2280-2285
[6]   TOPOISOMERASE-TARGETING ANTITUMOR DRUGS [J].
DARPA, P ;
LIU, LF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) :163-177
[7]   Iridoids as DNA topoisomerase I poisons [J].
Gálvez, M ;
Martín-Cordero, C ;
Ayuso, MJ .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2005, 20 (04) :389-392
[8]  
HSIANG YH, 1988, CANCER RES, V48, P1722
[9]  
Huang YW, 2006, ANTICANCER RES, V26, P3613
[10]   Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents [J].
Ishar, MPS ;
Singh, G ;
Singh, S ;
Sreenivasan, KK ;
Singh, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) :1366-1370